PI3K-IN-35
Modify Date: 2024-01-08 10:54:24
PI3K-IN-35 structure
|
Common Name | PI3K-IN-35 | ||
|---|---|---|---|---|
| CAS Number | 2458163-99-8 | Molecular Weight | 453.50 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H23N7O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PI3K-IN-35PI3K-IN-35 (Compound 6l) is a highly selective PI3K inhibitor with IC50 values of 13.98, 7.22 and 10.94 μM for PI3K-α、PI3K-β and PI3K-δ, respectively. PI3K-IN-35 arrests cell cycle at G2/M phase and induces apoptosis. PI3K-IN-35 can be used in leukemia research[1]. |
| Name | PI3K-IN-35 |
|---|
| Description | PI3K-IN-35 (Compound 6l) is a highly selective PI3K inhibitor with IC50 values of 13.98, 7.22 and 10.94 μM for PI3K-α、PI3K-β and PI3K-δ, respectively. PI3K-IN-35 arrests cell cycle at G2/M phase and induces apoptosis. PI3K-IN-35 can be used in leukemia research[1]. |
|---|---|
| Related Catalog | |
| Target |
PI3Kα:13.98 μM (IC50) PI3Kβ:7.22 μM (IC50) PI3Kδ:10.94 μM (IC50) |
| In Vitro | PI3K-IN-35 (Compound 6l) (10 μM, 48 hours) possess potent antiproliferative activity can inhibit proliferation of Leukemia SR cell lines in vitro[1]. PI3K-IN-35 (Compound 6l) induces cell cycle arrest toward the G2-M phase (41.61%) and leads to DNA synthesis and apoptosis[1]. PI3K-IN-35 (Compound 6l) (10 μM, 48 hours) results in apoptotic with 16.98% of cells in the early and latest age[1]. Cell Cytotoxicity Assay[1] Cell Line: Leukemia SR cell lines. Concentration: 10 μM Incubation Time: 48 hours Result: Antiproliferative activity with values of 13.59 μM. |
| References |
| Molecular Formula | C25H23N7O2 |
|---|---|
| Molecular Weight | 453.50 |